Tasigna

Tasigna

Basic Prescribing Info
Contents
Nilotinib
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EA03 - nilotinib ; Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in